Skip to main content

Table 2 Susceptibility testing for key species

From: Antibiotic treatment in acute exacerbation of COPD: patient outcomes with amoxicillin vs. amoxicillin/clavulanic acid—data from 43,636 outpatients

Capital region Susceptibility for AMC
Isolates tested (percent sensitive)
Susceptibility for AMX
Isolates tested (percent sensitive)
H. influenzae 275 (97%) 273 (81%)
M. catarrhalis 133 (99%) a
S. pneumoniae 109 (100%) 111 (94%)
Other 19 (79%) 53 (25%)
  1. a Should always be reported as R according to EUCAST